i2E, Inc. is a private equity general partner firm headquartered in Oklahoma City , OK , United States and has other offices in United States.
i2E led a $1.1m round for Biolytx Pharmaceuticals, which develops a drug promoting wound healing and killing antibiotic resistant bacteria.
WeGoLook, a provider of on-demand field inspection and verification services, has raised $1.5m in funding from i2E.
Moleculera Labs, which tests for autoimmune neurologic conditions in children and adults, has raised $1.06 in a funding round led by i2E.
Read more news concerning i2E, Inc.
A sampling of i2E, Inc. portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?